LIS
TGTX icon

Legacy Investment Solutions’s TG Therapeutics TGTX Stock Holding History

Legacy Investment Solutions’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$9.72K Buy
+270
New +$10.1K 0.01% 320
2024
Q4 		$8.94K Hold
270
– – 0.01% 304
2024
Q3 		$9.42K Buy
+270
New +$5.9K 0.01% 322

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Legacy Investment Solutions's TGTX Position: Q2 2025 in Review

Legacy Investment Solutions opened a new position in TG Therapeutics (TGTX) in Q2 2025: 270 shares worth $9.72K. The stake represents 0.01% of the portfolio and ranks #320 among its holdings. This is a return to the name: Legacy Investment Solutions previously reported a position in TGTX as recently as Q4 2024.

Legacy Investment Solutions first reported a position in TGTX in Q3 2024 and has held it in 3 quarters since. 356 funds tracked by Wall St. Rank hold TGTX as of Q2 2025.

  • Legacy Investment Solutions held 270 shares of TG Therapeutics worth $9.72K as of Q2 2025.
  • TG Therapeutics was a new Legacy Investment Solutions position in Q2 2025.
  • TG Therapeutics made up 0.01% of Legacy Investment Solutions's portfolio in Q2 2025, its #320 holding.
  • Legacy Investment Solutions first reported a position in TG Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • 356 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2025.

Based on Legacy Investment Solutions's 13F filing for Q2 2025, filed 6 Aug 2025.